United States Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market to 2031 - Featuring Canon, FUJIFILM Holdings, General Electric and Johnson & Johnson Among Others - ResearchAndMarkets.com
20 Feb 2023
Acquisition
DUBLIN--(BUSINESS WIRE)--The "U.S. Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market: Focus on Modality, Application, and End User - Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.
'U.S. Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market: Focus on Modality, Application, and End User - Analysis and Forecast, 2022-2031'
The U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market is segmented into U.S. orthopedic imaging modalities market and U.S. orthopedic surgical navigation systems market.
The report highlights that the U.S. orthopedic imaging modalities market was valued at $2,697.8 million in 2022 and is expected to reach $3,989.9 million by the end of 2031.
The market is expected to grow at a CAGR of 4.44% during the forecast period 2022-2031. The market is driven by factors such as technological advancements in the imaging field, the increasing incidences of orthopedic diseases and bone injuries, and the growing demand for point of care (POC) ultrasound systems in orthopedic applications.
In addition to this, the report also highlights that the U.S. orthopedic surgical navigation systems market was valued at $262.9 million in 2022 and is expected to reach $460.9 million by the end of 2031.
The market is expected to grow at a CAGR of 6.43% during the forecast period 2022-2031. The market is driven by factors such as the increasing number of joint replacement surgery and the increasing preference for minimally invasive surgery.
Market Lifecycle Stage
The U.S. orthopedic imaging modalities market is in the developed phase. The rising incidence of orthopedic indications and the upsurge in technological advancements are some of the major opportunities in the U.S. orthopedic imaging modalities market. Furthermore, some of the current key trends in the market are the inclination toward magnetic resonance imaging (MRI) systems and the integration of artificial intelligence (AI) in imaging modalities.
On the other hand, the U.S. orthopedic surgical navigation systems market is in the developing phase. The increasing preference for minimally invasive surgeries (MIS) and rising numbers of joint replacement surgeries are some of the major opportunities in the U.S. orthopedic surgical navigation systems market.
Recent Developments in the U.S. Orthopedic Imaging Modalities and U.S. Orthopedic Surgical Navigation Systems Market
In February 2022, FUJIFILM Holdings Corporation launched the Sonosite LX ultrasound system.
In December 2021, DePuy Synthes, a subsidiary of Johnson & Johnson, acquired OrthoSpin Ltd. to advance its innovation in the Medtech space.
In November 2021, FUJIFILM Holdings Corporation launched Persona CS Mobile Fluoroscopy System expanding its C-arm portfolio.
In September 2021, GE Healthcare, a subsidiary of General Electric Company, entered into an agreement to acquire BK Medical, a company that deals in surgical visualization. Through the acquisition, GE added a real-time surgical visualization field to the company's pre- and post-operative ultrasound capabilities.
In September 2021, Canon Inc. announced getting into a definitive agreement to acquire Redlen Technologies Inc. Through this acquisition, Canon Inc. aimed to expand and improve the medical business of the company.
Demand - Drivers and Limitations
U.S. Orthopedic Imaging Modalities Market
The following are the drivers for the U.S. orthopedic imaging modalities market:
Technological Advancements in Imaging
Increasing Incidences of Orthopedic Diseases and Bone Injuries
Growing Demand for POC Ultrasound Systems in Orthopedic
The market is expected to face some limitations as well due to the following challenges:
Health Risks and Healthcare Costs from Potentially Inappropriate High-Cost Imaging
Recall of Imaging Systems
U.S. Orthopedic Surgical Navigation Systems Market
The following are the drivers for the U.S. orthopedic surgical navigation systems market:
Increasing Number of Joint Replacement Surgeries
Increasing Preference for Minimally Invasive Procedures
The market is expected to face some limitations as well due to the following challenges:
High Cost of Robotic Navigation System
Companies Mentioned
Canon Inc.
Koninklijke Philips N.V.
Market Segmentation
U.S. Orthopedic Imaging Modalities Market
Segmentation 1: by Application
Hip
Knee
Spine
Other Extremities
The U.S. orthopedic imaging modalities devices market (by application) is expected to be dominated by the spine segment.
Segmentation 2: by Modality
X-Ray
Computed Tomography (CT) Scanners
Magnetic Resonance Imaging (MRI) Systems
Ultrasound Systems
The U.S. orthopedic imaging modalities devices market (by modality) is expected to be dominated by the X-Ray segment.
Segmentation 3: by End User
Hospitals
Ambulatory Surgery Centers
Others
The U.S. orthopedic imaging modalities devices market (by end user) is dominated by the hospitals segment.
U.S. Orthopedic Surgical Navigation Systems Market
Segmentation 1: by Application
Joints
Spine
The U.S. orthopedic surgical navigation systems market (by application) is expected to be dominated by the spine segment.
For more information about this report visit https://www.researchandmarkets.com/r/tee2hr-s-orthopedic?w=4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.